Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Chan, Carmen Wing Sze ^a   Kwong, Yok Lam ^a   Kwong, Raymond Y ^b   Lau, Chu Pak ^a   Tse, Hung Fat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HOSPITALIZATION; INJECTION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTION AND FORECASTING; TIME; TREATMENT OUTCOME;

AGED; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CONTRAST MEDIA; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; GADOLINIUM DTPA; HUMANS; INJECTIONS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77952508764     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-6     Document Type: Article

References (26)

1. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. HF Tse YL Kwong JK Chan G Lo CL Ho CP Lau, Lancet 2003 361 47 49 10.1016/S0140-6736(03)12111-3 12517468
2. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. EC Perin HF Dohmann R Borojevic SA Silva AL Sousa CT Mesquita MI Rossi AC Carvalho HS Dutra HJ Dohmann GV Silva L Belem R Vivacqua FO Rangel R Esporcatte YJ Geng WK Vaughn JA Assad ET Mesquita JT Willerson, Circulation 2003 107 2294 2302 10.1161/01.CIR.0000070596.30552.8B 12707230
3. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. A feasibility study. S Fuchs LF Satler R Kornowski P Okubagzi G Weisz R Baffour R Waksman NJ Weissman M Cerqueira MB Leon SE Epstein, J Am Coll Cardiol 2003 41 1721 1724 10.1016/S0735-1097(03)00328-0 12767654
4. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. C Briguori B Reimers C Sarais M Napodano P Pascotto G Azzarello M Bregni A Porcellini O Vinante P Zanco C Peschle G Condorelli A Colombo, Am Heart J 2006 151 674 80 10.1016/j.ahj.2005. 04.033 16504630
5. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. SL Beeres JJ Bax TA Kaandorp K Zeppenfeld HJ Lamb P Dibbets-Schneider MP Stokkel WE Fibbe A de Roos EE van der Wall MJ Schalij DE Atsma, Am J Cardiol 2006 97 1326 31 10.1016/j.amjcard.2005.11.068 16635605
6. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. LB Balsam AJ Wagers JL Christensen T Kofidis IL Weissman RC Robbins, Nature 2004 428 668 673 10.1038/nature02460 15034594
7. Stem cells: lost in translation. KR Chien, Nature 2004 428 607 8 10.1038/nature02500 15034595
8. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. T Kinnaird E Stabile MS Burnett M Shou CW Lee S Barr S Fuchs SE Epstein, Circulation 2004 109 1543 1549 10.1161/01.CIR.0000124062.31102.57 15023891
9. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells for enhancement of neovascularization in chronic ischemic myocardium. HF Tse CW Siu SG Zhu L Songyan QY Zhang WH Lai YL Kwong J Nicholls CP Lau, Eur J Heart Fail 2007 9 747 753 10.1016/j.ejheart.2007.03.008 17481945
10. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. RJ Kim DS Fieno TB Parrish K Harris EL Chen O Simonetti J Bundy JP Finn FJ Klocke RM Judd, Circulation 1999 100 1992 2002 10556226
11. Echo-planar magnetic resonance myocardial perfusion imaging: parametric map analysis and comparison with thallium SPECT. JR Panting PD Gatehouse GZ Yang M Jerosch-Herold N Wilke DN Firmin DJ Pennell, J Magn Reson Imaging 2001 13 192 200 10.1002/1522-2586(200102)13:2<192::AID-JMRI1029 3.0.CO;2-N 11169824
12. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. N Al-Saadi E Nagel M Gross A Bornstedt B Schnackenburg C Klein W Klimek H Oswald E Fleck, Circulation 2000 101 1379 83 10736280
13. Myocardial firstpass perfusion magnetic resonance imaging: a multicenter dose-ranging study. MG Friedrich DA Bluemke RW Biederman ET Martin AJ Lansky F Kashanian TK Foo PE Licato CR Comeau, Circulation 2004 110 732 737 10.1161/01.CIR.0000138106.84335.62 15289374
14. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. AT Yan AJ Shayne KA Brown SN Gupta CW Chan TM Luu MF Di Carli HG Reynolds WG Stevenson RY Kwong, Circulation 2006 114 34 39 10.1161/ CIRCULATIONAHA.106.613414
15. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for therapeutic angiogenesis in severe coronary artery diseases. HF Tse S Thambar YL Kwong P Rowlings G Bellamy J McCrohon P Thomas B Bastian JK Chan G Lo CL Ho WS Chan RY Kwong A Parker TH Hauser J Chan DY Fong CP Lau, Eur Heart J 2007 28 2998 3005 10.1093/eurheartj/ehm485 17984132
16. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. RY Kwong AK Chan KA Brown CW Chan GH Reynolds S Tsang RB Davis, Circulation 2006 113 2733 2743 10.1161/ CIRCULATIONAHA.105.570648 16754804
17. An improved MR imaging technique for the visualization of myocardial infarction. OP Simonetti RJ Kim DS Fieno HB Hillenbrand E Wu JM Bundy JP Finn RM Judd, Radiology 2001 218 215 223 11152805
18. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. K Alfakih S Reid T Jones M Sivananthan, Eur Radiol 2004 14 1813 1822 10.1007/s00330-004-2387-0 15258823
19. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the cardiac imaging committee of the council on clinically cardiology of the American Heart Association. MD Cerqueria NJ Weissman V Dilsizian AK Jacobs S Kaul WK Laskey DJ Pennell JA Rumberger T Ryan MS Verani, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441
20. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. N Wilke M Jerosch-Herold Y Wang, Radiology 1997 204 373 84 9240523
21. Transmyocardial laser revascularization preserves regional myocardial perfusion: an MRI first pass perfusion study. OM Muhling Y Wang P Panse M Jerosch-Herold MM Cayton LS Wann MM Mirhoseini NM Wilke, Cardiovasc Res 2003 57 63 70 10.1016/S0008-6363(02)00647-8 12504815
22. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. RJ Kim E Wu A Rafael EL Chen MA Parker O Simonetti FJ Klocke RO Bonow RM Judd, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
23. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. H Mahrholdt A Wagner TA Holly MD Elliott RO Bonow RJ Kim RM Judd, Circulation 2002 106 2322 2327 10.1161/01.CIR.0000036368.63317.1C 12403661
24. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. CE Murry MH Soonpaa H Reinecke H Nakajima HO Nakajima M Rubart KB Pasumarthi JI Virag SH Bartelmez V Poppa G Bradford JD Dowell DA Williams LJ Field, Nature 2004 428 664 668 10.1038/nature02446 15034593
25. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. H Kamihata H Matsubara T Nishiue S Fujiyama K Amano O Iba T Imada T Iwasaka, Arterioscler Thromb Vasc Biol 2002 22 1804 10 10.1161/01.ATV.0000039168.95670.B9 12426208
26. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. T Kinnaird E Stabile MS Burnett SE Epstein, Circ Res 2004 95 354 63 10.1161/01.RES.0000137878.26174. 66 15321945